|

Late post-transplant vaccination with Gardasil 9® Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Vastra Gotaland Region1

Indications

  • HPV (Human Papillomavirus)-Associated1
  • Recipients of Allogeneic Stem Cell Transplantation1
  • Acute Myeloid Leukaemia1
  • Diffuse Large B-cell Lymphoma(DLBCL)1
  • Myelodysplastic Syndrome1

Other1 trial

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.